Vanguard Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,767,268
| Closed | -$12.8M | – | 4197 |
|
|
2019
Q1 | $12.8M | Buy |
2,767,268
+655,261
| +31% | +$3.1M | ﹤0.01% | 2696 |
|
|
2018
Q4 | $7.39M | Sell |
2,112,007
-549,317
| -21% | -$3.82M | ﹤0.01% | 2914 |
|
|
2018
Q3 | $26.8M | Buy |
2,661,324
+119,776
| +5% | +$955K | ﹤0.01% | 2445 |
|
|
2018
Q2 | $18.4M | Buy |
2,541,548
+151,546
| +6% | +$1.06M | ﹤0.01% | 2600 |
|
|
2018
Q1 | $14.4M | Sell |
2,390,002
-147,084
| -6% | -$1.21M | ﹤0.01% | 2631 |
|
|
2017
Q4 | $24.4M | Buy |
2,537,086
+244,979
| +11% | +$1.6M | ﹤0.01% | 2413 |
|
|
2017
Q3 | $20.4M | Sell |
2,292,107
-41,147
| -2% | -$425K | ﹤0.01% | 2484 |
|
|
2017
Q2 | $29.5M | Sell |
2,333,254
-17,853
| -0.8% | -$211K | ﹤0.01% | 2282 |
|
|
2017
Q1 | $24.7M | Sell |
2,351,107
-29,785
| -1% | -$317K | ﹤0.01% | 2360 |
|
|
2016
Q4 | $21.9M | Sell |
2,380,892
-1,812
| -0.1% | -$20.5K | ﹤0.01% | 2385 |
|
|
2016
Q3 | $28.1M | Sell |
2,382,704
-2,077
| -0.1% | -$31.6K | ﹤0.01% | 2208 |
|
|
2016
Q2 | $30.9M | Sell |
2,384,781
-107,214
| -4% | -$1.56M | ﹤0.01% | 2131 |
|
|
2016
Q1 | $39.8M | Buy |
2,491,995
+216,373
| +10% | +$4.11M | ﹤0.01% | 1969 |
|
|
2015
Q4 | $65.2M | Buy |
2,275,622
+414,581
| +22% | +$11.5M | ﹤0.01% | 1757 |
|
|
2015
Q3 | $53M | Buy |
1,861,041
+61,149
| +3% | +$2.25M | ﹤0.01% | 1837 |
|
|
2015
Q2 | $64.7M | Buy |
1,799,892
+76,662
| +4% | +$2.39M | ﹤0.01% | 1796 |
|
|
2015
Q1 | $50.1M | Buy |
1,723,230
+469,136
| +37% | +$12.4M | ﹤0.01% | 1911 |
|
|
2014
Q4 | $26.4M | Sell |
1,254,094
-38,810
| -3% | -$767K | ﹤0.01% | 2139 |
|
|
2014
Q3 | $25.1M | Buy |
1,292,904
+306,126
| +31% | +$4.81M | ﹤0.01% | 2109 |
|
|
2014
Q2 | $15.4M | Buy |
986,778
+27,904
| +3% | +$451K | ﹤0.01% | 2315 |
|
|
2014
Q1 | $19.9M | Buy |
958,874
+574,430
| +149% | +$11.4M | ﹤0.01% | 2181 |
|
|
2013
Q4 | $4.96M | Buy |
384,444
+113,586
| +42% | +$1.58M | ﹤0.01% | 2804 |
|
|
2013
Q3 | $3.16M | Buy |
270,858
+20,331
| +8% | +$167K | ﹤0.01% | 2950 |
|
|
2013
Q2 | $1.16M | Buy |
+250,527
| New | +$918K | ﹤0.01% | 3266 |
|
Other funds holding INSY
WS
Vanguard Group's INSY Position: Q2 2019 in Review
Vanguard Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,767,268 shares — an estimated $12.8M sold.
Vanguard Group first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $65.2M in Q4 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Vanguard Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Vanguard Group sold 2,767,268 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $12.8M.
- Vanguard Group first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Vanguard Group's Insys Therapeutics, Inc. position peaked at $65.2M in Q4 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.